Genentech

XOLAIR

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / XOLAIR – J2357

Manufacturer:

Genentech

Name:

XOLAIR

HCPCS Code Descriptor:

Injection, omalizumab, 5 mg

Category:

J Code

HCPCS:

J2357

NDC(s):

50242-0214-01, 50242-0215-01, 50242-0040-62

Primary Type:

Anti-Eosinophil Asthma

Generic Status:

Single-Source

Route of Administration:

Subcutaneous

About:

XOLAIR is an Anti-Eosinophil Asthma drug manufactured by Genentech and administered via the Subcutaneous route of administration. The J Code: J2357 is aligned to the drug XOLAIR.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/05

HCPCS Effective Date:

1/1/05

HCPCS Short Description:

Omalizumab injection

Billing and Coding Guide:

https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/XOLAIR-Billing-Coding-for-Chronic-Spontaneous-Urticaria.pdf

Patient Assistance:

Not Found